Stay updated on ABP 959 vs Eculizumab in PNH: Clinical Trial
Sign up to get notified when there's something new on the ABP 959 vs Eculizumab in PNH: Clinical Trial page.

Latest updates to the ABP 959 vs Eculizumab in PNH: Clinical Trial page
- Check6 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record with an access-denied screen. It also removes most study content and Amgen-related documents from view.SummaryDifference20%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a minor software version update. No substantive changes to the study content are indicated by this change.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, representing a minor version update to the study record documentation. This change updates the metadata without altering the underlying study information or results.SummaryDifference0.0%

- Check63 days agoChange DetectedThe website revision was updated from v3.6.3 to v3.6.4, indicating a routine site maintenance or patch. There are no visible changes to study details, eligibility criteria, or results in this update.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page reflects a new software version (v3.6.3) by updating the revision label from v3.6.2; this indicates a backend/UI update rather than changes to the study information.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.6.2 replaces v3.6.0, signaling a newer version of the page or its documents. The update does not alter study data or participant details and appears to be administrative in nature.SummaryDifference0.0%

Stay in the know with updates to ABP 959 vs Eculizumab in PNH: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 959 vs Eculizumab in PNH: Clinical Trial page.